This inventor holds 1 USPTO granted patent and 1 published patent application and 1 EPO patent. Top assignee: Centro De Immunologia Molecular. Active years: 2017.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2017
Title: Amparo Emilia Macías Abraham: Pioneering Pharmaceutical Innovations
Introduction: Amparo Emilia Macías Abraham is an esteemed inventor based in La Habana, Cuba. She has made significant contributions to the field of pharmaceuticals, particularly in the treatment of malignant tumors. With her innovative approach, she is enhancing therapeutic strategies to address complex medical challenges.
Latest Patents: Amparo holds one patent titled "Pharmaceutical compositions for the treatment of tumors expressing EGFR and GM3 N-glycolyl ganglioside (NeuGcGM3)." This groundbreaking invention pertains to pharmaceutical compositions designed to treat malignant tumors that express specific targets, namely EGFR and GM3 N-glycolyl ganglioside. The compositions aim to improve the therapeutic effect of existing treatments through the integration of antibodies and vaccines targeting these critical markers. Additionally, she has developed methods for the effective application of these compositions, underscoring her commitment to advancing cancer treatment.
Career Highlights: Amparo is a prominent member of the Centro de Inmunología Molecular, where she leverages her expertise to drive research and innovation in immunology and pharmaceuticals. Her work is characterized by a dedication to improving patient outcomes through scientific exploration and discovery.
Collaborations: Throughout her career, Amparo has collaborated with talented professionals, including Adys González Palomo and Adriana Carr Pérez. These partnerships have fostered a synergistic environment, enabling the exchange of ideas and techniques that contribute to the advancement of their projects.
Conclusion: Amparo Emilia Macías Abraham is a visionary inventor whose work in pharmaceutical science is making a profound impact in the field of cancer treatment. Her innovative patent reflects a deep understanding of medical needs and exemplifies her commitment to improving health outcomes through targeted therapies. Her collaborations further enhance the potential of her research, setting a remarkable standard for future innovations in oncology.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile